Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2022) 86 P209 | DOI: 10.1530/endoabs.86.P209

SFEBES2022 Poster Presentations Metabolism, Obesity and Diabetes (96 abstracts)

Vitamin B12 deficiency induces de novo lipogenesis and lipid oxidation in human placental trophoblasts

Abha Abha 1 , Mark Christian 1 , Ponnusamy Saravanan 2,3 & Adaikalakoteswari Antonysunil 1


1Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom; 2Division of Health Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, Coventry, United Kingdom; 3Diabetes Centre, George Eliot Hospital NHS Trust College Street, Nuneaton, United Kingdom


Background: Obesity-linked metabolic disorders are a worldwide health concern affecting about one third of women of reproductive age. The programming events in utero impact the risk of predisposition to obesity and metabolic diseases. Maternal B12 deficiency is associated with higher cord lipids. B12 has a potential epigenetic role and therefore may perpetuate an intergenerational cycle of obesity through its effects on placental function and fetal metabolism. Therefore, we hypothesize that B12 deficiency could affect placental lipid metabolism and may alter fetal lipid levels, potentially influencing neonatal adiposity. Here, we assessed whether low B12 in human placental trophoblasts alters de novo fatty acid (FA) synthesis and oxidation.

Methods: Human trophoblastic choriocarcinoma cells (Bewo) were cultured using custom made Ham’s F12 media supplemented with sufficient (500nM-Control) or low concentrations of B12 media (25pM-low B12) until confluence was achieved. RNA isolation, cDNA synthesis and gene expression assays using RT-qPCR were employed to examine the expression of genes required for FA synthesis and oxidation.

Results: Placental trophoblasts cultured in low B12 showed significantly increased gene expression of (1) nuclear transcription factors regulating FA synthesis (SREBF1), oxidation (LDLR), adipogenesis (PPARγ, CEBPα), (2) de novo FA synthesis (ACLY, ACACA, FASN), FA elongation (ELOVL6), (3) triglyceride biosynthesis (GPAT, AGPAT, Lipin1, DGAT2) and (4) downregulated gene expression in FA oxidation (CPT1A, SLC25A2, ACADS, HADHB, HADHA) compared to control (P<0.05). We also observed deregulated expression of leptin, a major adipokine of placental lipid metabolism.

Conclusion: Our data provide evidence that low B12 potentially impacts lipid metabolism and deregulates leptin in placental trophoblasts. Thus, indicating that B12 deficiency could alter placental lipid levels which may lead to placental dysfunction and subsequent dyslipidemia in offspring. Future studies to elucidate the epigenetic mechanisms will support the development of effective interventions to optimize maternal metabolism, placental function and health of the offspring.

Volume 86

Society for Endocrinology BES 2022

Harrogate, United Kingdom
14 Nov 2022 - 16 Nov 2022

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.